EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Transcriptomic Profiling of Paired Primary Tumors and CNS Metastases in Breast Cancer Reveals Immune Modulation Signatures

Ana Julia Aguiar de Freitas iD, Muriele Bertagna Varuzza iD, Stéphanie Calfa iD, Rhafaela Lima Causin iD, Vinicius Duval da Silva iD, Cristiano de Pádua Souza iD, Márcia Maria Chiquitelli Marques iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26146944 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Ana Julia Aguiar de Freitas und 6 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Oncology Research Center, Teaching and Research Institute, Barretos Cancer Hospital, Barretos 14784-400, SP, Brazil. Hauptthemen laut MEDLINE: Breast Neoplasms, Gene Expression Profiling, Central Nervous System Neoplasms, Transcriptome. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sao Paulo Research Foundation (FAPESP), PhD Scholarship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is a leading cause of central nervous system (CNS) metastases in women, often associated with poor prognosis and limited therapeutic options. However, molecular differences between primary tumors and CNS metastases remain underexplored. We aimed to characterize transcriptomic differences between primary breast tumors and matched CNS metastases and identify immune-related biomarkers associated with metastatic progression and patient outcomes. Transcriptomic profiling was based on 11 matched FFPE sample pairs (primary tumor and CNS metastasis). Paired formalin-fixed paraffin-embedded (FFPE) samples from primary tumors (T1) and CNS metastases (T2) were analyzed using the NanoString nCounter® platform and the PanCancer IO 360™ Gene Expression Panel. Differential gene expression, Z-score transformation, and heatmap visualization were performed in R. In silico survival analyses for overall survival (OS) and recurrence-free survival (RFS) were conducted using publicly available TCGA and GEO datasets. Forty-five genes were significantly differentially expressed between the T1 and T2 samples. Immune-related genes such as CXCL9, IL7R, CD79A, and CTSW showed consistent downregulation in CNS metastases. High expression of CXCL9 and CD79A was associated with improved OS and RFS, whereas high IL7R and CTSW expression correlated with worse outcomes. These findings indicate immune suppression as a hallmark of CNS colonization. Comparative transcriptomic analysis further underscored the distinct molecular landscapes between primary and metastatic tumors. This study highlights transcriptional signatures associated with breast cancer CNS metastases, emphasizing the role of immune modulation in metastatic progression. The identified genes have potential as prognostic biomarkers and therapeutic targets, supporting the need for site-specific molecular profiling in metastatic breast cancer management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsGene Expression ProfilingCentral Nervous System NeoplasmsTranscriptomeHumansFemaleGene Expression Regulation, NeoplasticBiomarkers, TumorPrognosisMiddle Aged

Stichwörter der Autor:innen

CNS metastasesNanoStringbreast cancergene expressionimmune biomarkerspersonalized oncology

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Molecular Oncology Research Center, Teaching and Research Institute, Barretos Cancer Hospital, Barretos 14784-400, SP, Brazil.
  • Barretos Cancer Hospital, Barretos 14784-400, SP, Brazil.

ORCID-Profile: Ana Julia Aguiar de Freitas, Muriele Bertagna Varuzza, Stéphanie Calfa, Rhafaela Lima Causin, Vinicius Duval da Silva, Cristiano de Pádua Souza, Márcia Maria Chiquitelli Marques

Förderung

  • Sao Paulo Research Foundation (FAPESP)
  • PhD Scholarship

Zitieren

APA

Freitas, A. J. A., Varuzza, M. B., Calfa, S., Causin, R. L., Silva, V. D. D., Souza, C. P., & Marques, M. M. C. (2025). Transcriptomic Profiling of Paired Primary Tumors and CNS Metastases in Breast Cancer Reveals Immune Modulation Signatures. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26146944

Vancouver

Freitas AJA, Varuzza MB, Calfa S, Causin RL, Silva VDD, Souza CP, et al. Transcriptomic Profiling of Paired Primary Tumors and CNS Metastases in Breast Cancer Reveals Immune Modulation Signatures. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26146944

BibTeX
@article{Freitas2025,
  author = {Freitas, Ana Julia Aguiar de and Varuzza, Muriele Bertagna and Calfa, Stéphanie and Causin, Rhafaela Lima and Silva, Vinicius Duval da and Souza, Cristiano de Pádua and Marques, Márcia Maria Chiquitelli},
  title = {Transcriptomic Profiling of Paired Primary Tumors and CNS Metastases in Breast Cancer Reveals Immune Modulation Signatures},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26146944}
}
Kostenlos starten →